Sort
82,697 grants matching “vaccine development”
SPORE in Skin Cancer
$1,946,960Brigham And Women'S Hospital · P50 · FY2005 · CA
Adenovirus-based Anti-Cocaine Vaccine
$1,946,312Ronald G Crystal · Weill Medical Coll Of Cornell Univ · RC2 · FY2009 · DA
Mechanisms and Immunological Consequences of Host-Virus Interactions
$1,946,188Ulrich H Von Andrian · Harvard Medical School · P01 · FY2016 · AI
Identification of targets of CD4 and CD8 T cell reactivity conserved across Sarbecoviruses and recognized across different animal species
$1,946,055Alba Grifoni · Washington University · P01 · FY2022 · AI
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,946,004Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2016 · AI
Prophylactic Anthrax Toxin Vaccine
$1,945,441Vical, Inc. · R44 · FY2004 · AI
Miami Center for AIDS Research
$1,945,212Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2019 · AI
Natural History of HPV Infection in Men: The HIM Study
$1,944,747Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Optimizing HIV immunogen-BCR interactions for vaccine development
$1,944,717Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · P01 · FY2014 · AI
Mechanisms and Immunological Consequences of Host-Virus Interactions
$1,944,539Ulrich H Von Andrian · Harvard Medical School · P01 · FY2017 · AI
Molecular Studies on HIV Envelope for Vaccine Design
$1,944,381Dennis R. Burton · Maxygen, Inc. · P01 · FY2008 · AI
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
$1,943,996Luc Teyton · Scripps Research Institute, The · P01 · FY2024 · AI
Live Vector Vaccines Against Agents of Bioterror
$1,943,913James P. Nataro · University Of Maryland Baltimore · U19 · FY2006 · AI
Heterodimeric IL-15 in Cancer Immunotherapy
$1,943,565George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Facility Management, Maintenance and Operations (FMMO) Core
$1,943,533Deborah Ann Lazzarino · Rutgers Biomedical And Health Sciences · UC7 · FY2024 · AI
Malaria Vaccines: AMA1-C1/ALHYDROGEL + CPG 7909
$1,942,373Louis Miller · Niaid Extramural Activities · Z01 · FY2007 · AI
Malaria Vaccines: BSAM-1/ALHYDROGEL + CPG 7909
$1,942,373Louis Miller · Niaid Extramural Activities · Z01 · FY2007 · AI
Mucosal Immunopathogenesis of Franscisella Tularensis
$1,941,836Albany Medical College · P01 · FY2005 · AI
Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens
$1,941,828Utpal Pal · Univ Of Maryland, College Park · P01 · FY2025 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$1,941,623Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2011 · HG
SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT
$1,941,388Medical Research Council Of South Africa · U01 · FY2000 · AI
Clinical Research Support for the CCR
$1,940,721Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
Papillomavirus Virion Proteins and Vaccines
$1,940,563John T. Schiller · Basic Sciences · Z01 · FY2007 · CA
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,940,003Nelson Lee Michael · Walter Reed Army Institute Of Research · UM1 · FY2016 · AI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,939,404Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA